Skip to content

DENTSPLY SIRONA XRAY Free cash flow

Free cash flow at other companies

Envista Holdings Corporation logo
Envista Holdings CorporationNVST
-$15.8M-182%
Stryker logo
StrykerSYK
$415M+227%
Align Technology logo
Align TechnologyALGN
Solventum logo
SolventumSOLV
Henry Schein logo
Henry ScheinHSIC
Globus Medical logo
Globus MedicalGMED

Other financials

Income statement

See full
Revenue$880.0M+0.1%
Gross profit$427.0M-8.4%
Operating income-$35.0M-156%
Net income-$10.0M-150%
EPS (diluted)-$0.05-150%

Balance sheet

See full
Cash & equivalents$190.0M-52.3%
Total debt$2.3B-3.8%
Total equity$1.3B-34.4%
Total assets$5.2B-13.6%

Cash flow

See full
Operating cash flow$40.0M+471%
CapEx$52.0M+174%

Valuation

See full
Market cap$2.04B-22.1%
Enterprise value$4.18B-10.8%
P/S0.6×-0.2×

Profitability

See full
Gross margin48.9%-2.6pp
Operating margin-14.1%-3.9pp
Net margin-17.1%-3.9pp
FCF margin2.8%-4.6pp

Returns & leverage

See full
Return on equity-37.7%+4.0pp
Debt / equity1.8×+0.6×
Current ratio1.5×+0.4×

Where this comes from

Calculated from DENTSPLY SIRONA’s reported figures.

The official record: DENTSPLY SIRONA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about DENTSPLY SIRONA's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DENTSPLY SIRONA's free cash flow?
DENTSPLY SIRONA (XRAY) reported free cash flow of -$12M in Q1 2026.
How has DENTSPLY SIRONA's free cash flow changed year-over-year?
DENTSPLY SIRONA's free cash flow decreased by 0.0% year-over-year, from -$12M to -$12M.
What is the long-term trend for DENTSPLY SIRONA's free cash flow?
Over 4 years (2021 to 2025), DENTSPLY SIRONA's free cash flow has grown at a -33.0% compound annual growth rate (CAGR), from $515M to $104M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.